1087.80EUR+0.28%Mkt Cap: 1.06T $P/E: 42.381d ago
Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally. The company offers cardiometabolic health products, incl…
Industry Peers
Drug Manufacturers - GeneralKey Statistics
Company
Market Cap1.06T $
Enterprise Value1.07T $
Revenue (TTM)86.59B $
Gross Profit58.83B $
Net Income (TTM)22.43B $
Revenue/Share96.76 USD
Last Price1087.80 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees50.0K
CountryDE
SectorHealthcare
IndustryDrug Manufacturers - General
ISINUS5324571083
Valuation
P/E (Trailing)42.38
P/E (Forward)148.60
PEG1.49
EV/EBITDA23.62
EV/Revenue12.37
P/S11.79
P/B34.36
EPS (TTM)25.76
EPS (Forward)7.09
52W Range
1021.6078% of range1107.00
52W High1107.00 EUR
52W Low1021.60 EUR
Profitability
Gross Margin83.04%
Oper. Margin54.22%
EBITDA Margin52.35%
Profit Margin31.67%
ROE77.78%
ROA18.35%
Growth
Revenue Growth47.70%
Earnings Growth26.20%
Cash Flow & Leverage
Operating CF18.27B $
CapEx (TTM)11.79B $
FCF Margin13.89%
FCF Yield1.14%
Net Debt49.95B $
Net Debt/EBITDA1.10
Balance Sheet
Debt/Equity1.60
Current Ratio1.35
Quick Ratio0.68
Book Value/Sh30.67 EUR
Cash/Share10.04 EUR
Dividends
Fwd Div Rate5.990 EUR
Trail. Div Rate6.460 EUR
Div. Yield0.58%
5Y Avg Yield0.88%
Payout Ratio21.69%
Ex-Div DateAug 14, 2026
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.891.36M
Float888.95M
Insiders0.16%
Institutions85.57%
Technical
SMA 501022.74 (+6.4%)
SMA 200906.88 (+19.9%)
Beta0.51
S&P 52W Chg20.80%
Avg Vol (30d)991
Avg Vol (10d)1.26K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—